Amol Patwardhan, PhD
Pain Medicine · Dallas, TXNPI 1871827725
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,675 of the $2,658 with a category attached, or 63.0%. 10 manufacturers reported payments, led by Spinal Simplicity, LLC at 39.1% of the total. Reporting peaked in 2022 at $1,040 and has fallen 87.8% since, to $126 in 2025. That places this record below the midpoint for pain medicine clinicians in TX, where the typical reported total is $3,132.
Across 34 payments — averaging $78.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spinal Simplicity, LLC$1K
- Stryker$560
- Boston Scientific$412
- Vertos Medical, Inc.$367
- Saluda Medical Americas, Inc.$71
- Medtronic$62
- plus $146 from 4 others
Across 47 payments — averaging $3711.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$174K
What the payments were for
- Travel & lodging$1,67563%
- Food & beverage$98237%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spinal Simplicity, LLC | 8 | $1,040 |
| Stryker | 4 | $560 |
| Boston Scientific | 9 | $412 |
| Vertos Medical, Inc. | 5 | $367 |
| Saluda Medical Americas, Inc. | 2 | $71 |
| Medtronic | 1 | $62 |
| SPR Therapeutics, Inc | 1 | $59 |
| GRT US Holding, Inc. | 1 | $30 |
| Abbott | 2 | $30 |
| Baxter Healthcare | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,658 in reported general payments places this provider in the 45th percentile of 583 pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 85 | $1,312 |
| Pregabalin | 24 | $559 |
| Tizanidine Hcl | 22 | $393 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $129 |
| Meloxicam | 12 | $32 |
| Nortriptyline Hcl | 11 | $29 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Dallas
- Justin ThompsonDallas$45K
- Demaceo HowardDallas$39K
- Melissa MurphyGrapevine$653K
- Shiraz YazdaniLubbock$514K
- Aaron CalodneyTyler$296K
- Candice BurnetteSugar Land$265K
- Ashley Bailey-ClassenFort Worth$244K
- Grant ChenHouston$175K
- Gunjan PatelHouston$166K
- Anthony BergRockwall$165K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.